22 results on '"Villadsen, Anton Boel"'
Search Results
2. Randomized Comparison of the Polymer-Free Biolimus-Coated BioFreedom Stent With the Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Orsiro Stent in an All-Comers Population Treated With Percutaneous Coronary Intervention: The SORT OUT IX Trial
3. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial
4. Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial
5. Outcome in high risk patients with unprotected left main coronary artery stenosis treated with percutaneous coronary intervention
6. Everolimus-Eluting Versus Biolimus-Eluting Stents With Biodegradable Polymers in Unselected Patients Undergoing Percutaneous Coronary Intervention:A Randomized Noninferiority Trial With 1-Year Follow-Up (SORT OUT VIII Trial)
7. Acute Coronary Artery Thrombosis and a Giant Coronary Artery Aneurysm: An Atypical Combination and an Unconventional Catheter-Based Intervention
8. Establishing a dedicated program for treating chronic coronary total occlusions. Clinical results before and after routinely using retrograde revascularization techniques
9. Impact of Diabetes on Clinical Outcomes after Revascularization with Sirolimus-eluting and Birolimus-Eluting Stents with biodegradable polymer. From the SORT OUT VII Trial
10. Impact of diabetes on clinical outcomes after revascularization with sirolimus‐eluting and biolimus‐eluting stents with biodegradable polymer from the SORT OUT VII trial.
11. Short Versus Long-Term Clinical Outcomes In A Randomised Comparison Of Zotarolimus- and Sirolimus-Eluting Coronary Stents
12. Randomized Comparison of Everolimus-Eluting and Sirolimus-Eluting Stents in Patients Treated with Percutaneous Coronary Intervention (The SORT OUT IV Trial)
13. Acute coronary artery thrombosis and a giant coronary artery aneurysm:an atypical combination and an unconventional catheter-based intervention
14. Chronic total coronary occlusion: treatment results.
15. Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease.
16. Randomized Comparison of a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent With a Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention The SORT OUT VII Trial.
17. LONG–TERM OUTCOME AFTER REVASCULARIZATION WITH EVEROLIMUS– AND SIROLIMUS–ELUTING STENTS IN PATIENTS WITH RENAL INSUFFICIENCY: FROM THE SORT OUT IV TRIAL
18. Randomized Comparison of Everolimus-Eluting and Sirolimus-Eluting Stents in Patients Treated With Percutaneous Coronary Intervention: The Scandinavian Organization for Randomized Trials With Clinical Outcome IV (SORT OUT IV).
19. Percutaneous transluminal coronary angioplasty versus thrombolysis in acute myocardial infarction.
20. Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial.
21. TCT-290 Establishing a dedicated program for treating chronic coronary total occlusions. Clinical results before and after routinely using retrograde revascularization techniques.
22. TCT-261 Impact of Diabetes on Clinical Outcomes after Revascularization with Sirolimus-eluting and Birolimus-Eluting Stents with biodegradable polymer. From the SORT OUT VII Trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.